SEC Filings
CRH Sells Two €750 Million Bond Issues With Parent Guarantees
The later-maturing bonds carry a higher interest rate, and CRH expects to use the net proceeds for general corporate purposes.
SEC Filings
The later-maturing bonds carry a higher interest rate, and CRH expects to use the net proceeds for general corporate purposes.
SEC Filings
Meta made up about 38% of disclosed value in the WhatsApp co-founder's family office portfolio.
SEC Filings
Larimar's projected cash runway extends into late second quarter 2027, before its anticipated mid-2027 U.S. approval.
SEC Filings
The drugmaker plans two FDA applications in 2027, including a broader initial request covering cancers that did not respond to BCG.
SEC Filings
The investment adviser and Daniel Sundheim reported shared voting power over the same shares and certified a passive position.
SEC Filings
Daniel Sundheim reported the same shares through his indirect control of D1, the investment manager.
SEC Filings
The investment manager and its controller reported the same position, with shared voting authority across all 45,896,143 shares.
SEC Filings
The new chief led ADSTILADRIN's pivotal program, while Relmada targets a year-end submission for its own bladder-cancer candidate.
SEC Filings
Common-share issuance financed most of the preferred-stock repurchases, while Strategy kept Stretch's annual dividend rate at 12%.
SEC Filings
Adverse events caused 12.9% of the highest-dose group to stop treatment; previously reported weight loss averaged 5% at 12 weeks.
SEC Filings
Breast-cancer trial results are expected in the second half of 2027; an earlier solid-tumor readout is due in December.
SEC Filings
The kidney-drug company can request another $80 million, but lenders decide whether to provide it.